Grand finale for Scientia Fellows
The Faculty of Medicine are currently recruiting approximately 40 international research talents to excellent research environments.
Nolwenn Briand was one of the first Scientia fellows. Now, 38 positions are open for applications.
“This is the final chance to apply to UiO’s largest EU programme, Scientia Fellows II. There is a very high level of candidates applying for the programme, within the full spectrum of health and life science research. These international research talents will contribute greatly to both research and innovation in the years ahead at the University of Oslo”, says Hilde Nebb, coordinator of Scientia Fellows and Vice-Dean of Innovation and Internationalisation.
Approximately 100 researchers (250 person years) will be employment after this round of recruitment. That is the framework for the 5-year EU project (2019-2024).
Internationalisation of life science research
38 positions in 32 different research areas are open for applications. The duration of the positions stretch from one to three years. The researchers work either in research communities at UiO or in international research communities that collaborate with prominent communities at UiO. During the first five-year period, more than 80 excellent researchers from 33 countries contributed to research, innovation and internationalisation in many of UiO’s best medical research communities.
“In addition to creating and carrying out their own research projects, the fellows have access to the Postdoctoral programme, the School of Health Innovation and other programmes which focus on transferable skills that can further expand career opportunities. This is very attractive to international applicants and Scientia Fellows has gained a great reputation internationally”, says Nebb.
This year, there are also several collaborations between our research communities and industry regarding fellows. Bayer, GE Healthcare, and GlaxoSmithKline have seen the value of a concrete collaboration opportunity with UiO through the Scientia Fellows programme.
“We are working diligently to create collaboration and synergy between the business-sector and academia. This collaboration is an important contribution that will open doors to innovative and business-oriented research, and will also benefit society and patients”, concludes Nebb.